We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SKWD posted 26.7% revenue growth and 46% EPS growth in Q4, with an improved combined ratio.
SKWD leverage is set to rise to 28-29% after the Apollo deal, above the industry's 15.4% average.
Skyward Specialty Insurance Group, Inc. (SKWD - Free Report) has struggled to keep pace with the broader market despite delivering strong operating results. Shares are down 15.1% year to date, lagging both the industry and the S&P 500, while peers like Allstate Corporation (ALL - Free Report) and Heritage Insurance (HRTG - Free Report) have seen more modest declines.
YTD Price Performance – SKWD, ALL, HRTG, Industry & S&P 500
Image Source: Zacks Investment Research
That gap brings the focus to a key question: is the pullback an opportunity, or a signal of rising risks?
Let’s dig deeper.
The P&C cycle appears to be easing, with pricing momentum slowing and competition picking up. Skyward ended 2025 with debt-to-capital below 11%, but that is expected to rise to 28–29% following the Apollo acquisition. Meanwhile, the industry average for total debt to total capital was at 15.4% at the end of 2025. Even if the deal is strategically sound, the jump in leverage introduces near-term uncertainty.
Does Valuation Reflect Skepticism?
On valuation, SKWD appears inexpensive on the surface. The stock trades at about 9.24X forward 12-month earnings compared with its three-year median of 12.92X and 26.77X of the industry. Meanwhile, peers like Allstate and Heritage aren’t exactly expensive either, trading at 8.12X and 5.89X forward earnings, respectively.
Image Source: Zacks Investment Research
Execution Remains Strong as Mix Evolves
Operationally, the company continues to deliver. Fourth-quarter 2025 revenue grew 26.7% year over year to $385.6 million, while adjusted earnings rose 46% to $1.17 per share. Underwriting execution supported the results.
Gross written premiums witnessed strong momentum, supported by Specialty Programs, Accident & Health and Surety. Also, the combined ratio improved 730 basis points from the prior-year quarter to 88.5%, while underwriting income jumped to $41 million, up roughly 235% year over year. Those are tangible markers that profitability improved alongside growth.
The core bull case centers on a more cycle-resilient earnings mix. Roughly half of the portfolio is positioned in areas viewed as less exposed to traditional property and casualty cycles, helping the company emphasize risk-adjusted returns rather than pure volume. The Apollo acquisition adds another lever with capital-light fee income and profit-commission upside.
What Do Estimates for SKWD Say?
The Zacks Consensus Estimate for 2026 and 2027 revenues points to a year-over-year increase of 26.4% and 12.2%, respectively. The jump aligns with mix shift and Apollo integration. The consensus mark for 2026 and 2027 earnings signal 18.3% and 14.8% growth, respectively. It has witnessed two upward estimate revisions over the past month and no downward movement. SKWD beat earnings estimates in each of the past four quarters, with an average surprise of 16.1%
Skyward Specialty Insurance Group, Inc. Price, Consensus and EPS Surprise
The pullback in Skyward reflects higher leverage and more cautious industry expectations rather than any meaningful deterioration in fundamentals. While near-term sentiment may stay restrained, strong execution and an evolving, more diversified earnings mix support the longer-term outlook. Backed by positive estimate revisions and a solid growth outlook, SKWD currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is Skyward Stock a Buy After the Pullback and Higher Leverage?
Key Takeaways
Skyward Specialty Insurance Group, Inc. (SKWD - Free Report) has struggled to keep pace with the broader market despite delivering strong operating results. Shares are down 15.1% year to date, lagging both the industry and the S&P 500, while peers like Allstate Corporation (ALL - Free Report) and Heritage Insurance (HRTG - Free Report) have seen more modest declines.
YTD Price Performance – SKWD, ALL, HRTG, Industry & S&P 500
That gap brings the focus to a key question: is the pullback an opportunity, or a signal of rising risks?
Let’s dig deeper.
The P&C cycle appears to be easing, with pricing momentum slowing and competition picking up. Skyward ended 2025 with debt-to-capital below 11%, but that is expected to rise to 28–29% following the Apollo acquisition. Meanwhile, the industry average for total debt to total capital was at 15.4% at the end of 2025. Even if the deal is strategically sound, the jump in leverage introduces near-term uncertainty.
Does Valuation Reflect Skepticism?
On valuation, SKWD appears inexpensive on the surface. The stock trades at about 9.24X forward 12-month earnings compared with its three-year median of 12.92X and 26.77X of the industry. Meanwhile, peers like Allstate and Heritage aren’t exactly expensive either, trading at 8.12X and 5.89X forward earnings, respectively.
Execution Remains Strong as Mix Evolves
Operationally, the company continues to deliver. Fourth-quarter 2025 revenue grew 26.7% year over year to $385.6 million, while adjusted earnings rose 46% to $1.17 per share. Underwriting execution supported the results.
Gross written premiums witnessed strong momentum, supported by Specialty Programs, Accident & Health and Surety. Also, the combined ratio improved 730 basis points from the prior-year quarter to 88.5%, while underwriting income jumped to $41 million, up roughly 235% year over year. Those are tangible markers that profitability improved alongside growth.
The core bull case centers on a more cycle-resilient earnings mix. Roughly half of the portfolio is positioned in areas viewed as less exposed to traditional property and casualty cycles, helping the company emphasize risk-adjusted returns rather than pure volume. The Apollo acquisition adds another lever with capital-light fee income and profit-commission upside.
What Do Estimates for SKWD Say?
The Zacks Consensus Estimate for 2026 and 2027 revenues points to a year-over-year increase of 26.4% and 12.2%, respectively. The jump aligns with mix shift and Apollo integration. The consensus mark for 2026 and 2027 earnings signal 18.3% and 14.8% growth, respectively. It has witnessed two upward estimate revisions over the past month and no downward movement. SKWD beat earnings estimates in each of the past four quarters, with an average surprise of 16.1%
Skyward Specialty Insurance Group, Inc. Price, Consensus and EPS Surprise
Skyward Specialty Insurance Group, Inc. price-consensus-eps-surprise-chart | Skyward Specialty Insurance Group, Inc. Quote
Bottom Line
The pullback in Skyward reflects higher leverage and more cautious industry expectations rather than any meaningful deterioration in fundamentals. While near-term sentiment may stay restrained, strong execution and an evolving, more diversified earnings mix support the longer-term outlook. Backed by positive estimate revisions and a solid growth outlook, SKWD currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.